Literature DB >> 22556366

Analysis of case-control association studies with known risk variants.

Noah Zaitlen1, Bogdan Pasaniuc, Nick Patterson, Samuela Pollack, Benjamin Voight, Leif Groop, David Altshuler, Brian E Henderson, Laurence N Kolonel, Loic Le Marchand, Kevin Waters, Christopher A Haiman, Barbara E Stranger, Emmanouil T Dermitzakis, Peter Kraft, Alkes L Price.   

Abstract

MOTIVATION: The question of how to best use information from known associated variants when conducting disease association studies has yet to be answered. Some studies compute a marginal P-value for each Several Nucleotide Polymorphisms independently, ignoring previously discovered variants. Other studies include known variants as covariates in logistic regression, but a weakness of this standard conditioning strategy is that it does not account for disease prevalence and non-random ascertainment, which can induce a correlation structure between candidate variants and known associated variants even if the variants lie on different chromosomes. Here, we propose a new conditioning approach, which is based in part on the classical technique of liability threshold modeling. Roughly, this method estimates model parameters for each known variant while accounting for the published disease prevalence from the epidemiological literature.
RESULTS: We show via simulation and application to empirical datasets that our approach outperforms both the no conditioning strategy and the standard conditioning strategy, with a properly controlled false-positive rate. Furthermore, in multiple data sets involving diseases of low prevalence, standard conditioning produces a severe drop in test statistics whereas our approach generally performs as well or better than no conditioning. Our approach may substantially improve disease gene discovery for diseases with many known risk variants. AVAILABILITY: LTSOFT software is available online http://www.hsph.harvard.edu/faculty/alkes-price/software/.

Mesh:

Year:  2012        PMID: 22556366      PMCID: PMC3381970          DOI: 10.1093/bioinformatics/bts259

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  32 in total

1.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

3.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

Authors:  Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

4.  What's the best statistic for a simple test of genetic association in a case-control study?

Authors:  Chia-Ling Kuo; Eleanor Feingold
Journal:  Genet Epidemiol       Date:  2010-04       Impact factor: 2.135

Review 5.  Linkage disequilibrium in humans: models and data.

Authors:  J K Pritchard; M Przeworski
Journal:  Am J Hum Genet       Date:  2001-06-14       Impact factor: 11.025

6.  The inheritance of liability to diseases with variable age of onset, with particular reference to diabetes mellitus.

Authors:  D S Falconer
Journal:  Ann Hum Genet       Date:  1967-08       Impact factor: 1.670

Review 7.  The epidemiology of autoimmune diseases.

Authors:  Glinda S Cooper; Berrit C Stroehla
Journal:  Autoimmun Rev       Date:  2003-05       Impact factor: 9.754

8.  Multi-locus test conditional on confirmed effects leads to increased power in genome-wide association studies.

Authors:  Li Ma; Shizhong Han; Jing Yang; Yang Da
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

Review 9.  Epistasis and its implications for personal genetics.

Authors:  Jason H Moore; Scott M Williams
Journal:  Am J Hum Genet       Date:  2009-09       Impact factor: 11.025

10.  Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.

Authors:  Sergey Nejentsev; Joanna M M Howson; Neil M Walker; Jeffrey Szeszko; Sarah F Field; Helen E Stevens; Pamela Reynolds; Matthew Hardy; Erna King; Jennifer Masters; John Hulme; Lisa M Maier; Deborah Smyth; Rebecca Bailey; Jason D Cooper; Gloria Ribas; R Duncan Campbell; David G Clayton; John A Todd
Journal:  Nature       Date:  2007-11-14       Impact factor: 49.962

View more
  19 in total

1.  Mixed model with correction for case-control ascertainment increases association power.

Authors:  Tristan J Hayeck; Noah A Zaitlen; Po-Ru Loh; Bjarni Vilhjalmsson; Samuela Pollack; Alexander Gusev; Jian Yang; Guo-Bo Chen; Michael E Goddard; Peter M Visscher; Nick Patterson; Alkes L Price
Journal:  Am J Hum Genet       Date:  2015-04-16       Impact factor: 11.025

2.  Accurate liability estimation improves power in ascertained case-control studies.

Authors:  Omer Weissbrod; Christoph Lippert; Dan Geiger; David Heckerman
Journal:  Nat Methods       Date:  2015-02-09       Impact factor: 28.547

3.  Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.

Authors:  Jesse Mez; Jaeyoon Chung; Gyungah Jun; Joshua Kriegel; Alexandra P Bourlas; Richard Sherva; Mark W Logue; Lisa L Barnes; David A Bennett; Joseph D Buxbaum; Goldie S Byrd; Paul K Crane; Nilüfer Ertekin-Taner; Denis Evans; M Daniele Fallin; Tatiana Foroud; Alison Goate; Neill R Graff-Radford; Kathleen S Hall; M Ilyas Kamboh; Walter A Kukull; Eric B Larson; Jennifer J Manly; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Gerard D Schellenberg; Kathryn L Lunetta; Lindsay A Farrer
Journal:  Alzheimers Dement       Date:  2016-10-20       Impact factor: 21.566

4.  Testing calibration of risk models at extremes of disease risk.

Authors:  Minsun Song; Peter Kraft; Amit D Joshi; Myrto Barrdahl; Nilanjan Chatterjee
Journal:  Biostatistics       Date:  2014-07-14       Impact factor: 5.899

5.  Local Joint Testing Improves Power and Identifies Hidden Heritability in Association Studies.

Authors:  Brielin C Brown; Alkes L Price; Nikolaos A Patsopoulos; Noah Zaitlen
Journal:  Genetics       Date:  2016-05-06       Impact factor: 4.562

6.  Efficient Estimation and Applications of Cross-Validated Genetic Predictions to Polygenic Risk Scores and Linear Mixed Models.

Authors:  Joel Mefford; Danny Park; Zhili Zheng; Arthur Ko; Mika Ala-Korpela; Markku Laakso; Päivi Pajukanta; Jian Yang; John Witte; Noah Zaitlen
Journal:  J Comput Biol       Date:  2020-02-20       Impact factor: 1.479

7.  Effective genetic-risk prediction using mixed models.

Authors:  David Golan; Saharon Rosset
Journal:  Am J Hum Genet       Date:  2014-10-02       Impact factor: 11.025

8.  A Novel Test for Detecting SNP-SNP Interactions in Case-Only Trio Studies.

Authors:  Brunilda Balliu; Noah Zaitlen
Journal:  Genetics       Date:  2016-02-10       Impact factor: 4.562

9.  Advantages and pitfalls in the application of mixed-model association methods.

Authors:  Jian Yang; Noah A Zaitlen; Michael E Goddard; Peter M Visscher; Alkes L Price
Journal:  Nat Genet       Date:  2014-02       Impact factor: 38.330

10.  Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population.

Authors:  Karol Estrada; Ingvild Aukrust; Lise Bjørkhaug; Noël P Burtt; Josep M Mercader; Humberto García-Ortiz; Alicia Huerta-Chagoya; Hortensia Moreno-Macías; Geoffrey Walford; Jason Flannick; Amy L Williams; María J Gómez-Vázquez; Juan C Fernandez-Lopez; Angélica Martínez-Hernández; Silvia Jiménez-Morales; Federico Centeno-Cruz; Elvia Mendoza-Caamal; Cristina Revilla-Monsalve; Sergio Islas-Andrade; Emilio J Córdova; Xavier Soberón; María E González-Villalpando; E Henderson; Lynne R Wilkens; Loic Le Marchand; Olimpia Arellano-Campos; Maria L Ordóñez-Sánchez; Maribel Rodríguez-Torres; Rosario Rodríguez-Guillén; Laura Riba; Laeya A Najmi; Suzanne B R Jacobs; Timothy Fennell; Stacey Gabriel; Pierre Fontanillas; Craig L Hanis; Donna M Lehman; Christopher P Jenkinson; Hanna E Abboud; Graeme I Bell; Maria L Cortes; Michael Boehnke; Clicerio González-Villalpando; Lorena Orozco; Christopher A Haiman; Teresa Tusié-Luna; Carlos A Aguilar-Salinas; David Altshuler; Pål R Njølstad; Jose C Florez; Daniel G MacArthur
Journal:  JAMA       Date:  2014-06-11       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.